Somatostatin [Neurosurgery Wiki]

This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong.

====== Somatostatin ======
(also known as [[growth hormone]]-inhibiting hormone (GHIH) or somatotropin release-inhibiting factor (SRIF)) or somatotropin release-inhibiting hormone is a [[peptide hormone]] that regulates the endocrine system and affects neurotransmission and cell proliferation via interaction with G protein-coupled somatostatin receptors and inhibition of the release of numerous secondary hormones. Somatostatin inhibits [[insulin]] and [[glucagon]] secretion.

Somatostatin treatment can induce extensive fibrosis in [[GH secreting pituitary neuroendocrine tumor]]
((Kerschbaumer J, Pinggera D, Moser P, Hofmann A, Thomé C, Freyschlag CF.
Somatostatin treatment can induce extensive fibrosis in growth hormone-producing 
adenoma. Acta Neurochir (Wien). 2016 Mar;158(3):441-3. doi:
10.1007/s00701-016-2714-7. Epub 2016 Jan 23. PubMed PMID: 26801514.
)).

===== Somatostatin receptor =====

see [[somatostatin receptor]].

===== Somatostatin analogs =====
[[Somatostatin analog]]s